13 Mar 2017 08:31
RNS Number : 2550Z
Immunodiagnostic Systems Hldgs PLC
13 March 2017
Immunodiagnostic Systems Holdings plc.
13 March 2017
Further re CEO Appointment
Immunodiagnostic Systems Holdings plc ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market confirms that incoming CEO, Regis Duval, is the beneficial owner of 29,397 ordinary shares of 2p each in the Company. This disclosure is made in accordance with AIM Rule 17. Regis Duval acquired these shares prior to joining IDS.
For further information:
Immunodiagnostic Systems Holdings plc Tel: +44 (0) 191 519 0660
Paul Martin, Group Finance Director
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
IDH.L (IDH)